Innovent Biologics Correlations
| IVBXF Stock | USD 5.32 0.26 5.14% |
The current 90-days correlation between Innovent Biologics and Genscript Biotech is 0.06 (i.e., Significant diversification). The correlation of Innovent Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Innovent Biologics Correlation With Market
Good diversification
The correlation between Innovent Biologics and DJI is -0.07 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Innovent Biologics and DJI in the same portfolio, assuming nothing else is changed.
Innovent |
The ability to find closely correlated positions to Innovent Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Innovent Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Innovent Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Innovent Biologics to buy it.
Moving together with Innovent Pink Sheet
| 0.64 | VRTX | Vertex Pharmaceuticals | PairCorr |
| 0.72 | JNJ | Johnson Johnson | PairCorr |
| 0.72 | TRV | The Travelers Companies | PairCorr |
| 0.66 | PG | Procter Gamble | PairCorr |
| 0.74 | T | ATT Inc Earnings Call Tomorrow | PairCorr |
| 0.74 | KO | Coca Cola | PairCorr |
Moving against Innovent Pink Sheet
| 0.81 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.73 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.71 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.62 | CSLLY | CSL | PairCorr |
| 0.6 | DCGO | DocGo Inc | PairCorr |
| 0.54 | PTAIY | Astra International Tbk | PairCorr |
| 0.49 | TLKMF | Telkom Indonesia Tbk | PairCorr |
| 0.48 | CMXHF | CSL Limited | PairCorr |
| 0.46 | DIS | Walt Disney | PairCorr |
| 0.81 | CAT | Caterpillar | PairCorr |
| 0.73 | AXP | American Express | PairCorr |
| 0.7 | MSFT | Microsoft | PairCorr |
| 0.66 | BAC | Bank of America | PairCorr |
| 0.63 | AA | Alcoa Corp | PairCorr |
| 0.55 | HPQ | HP Inc | PairCorr |
| 0.34 | BA | Boeing | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Innovent Pink Sheet performing well and Innovent Biologics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Innovent Biologics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TLPPF | 2.66 | 0.25 | 0.08 | (1.01) | 3.23 | 7.58 | 20.22 | |||
| KROS | 2.63 | (0.73) | 0.00 | 9.16 | 0.00 | 4.41 | 19.64 | |||
| MAIA | 3.47 | (0.06) | 0.00 | (0.20) | 0.00 | 7.08 | 26.04 | |||
| GRPH | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CLRPF | 4.38 | (0.48) | 0.00 | (1.60) | 0.00 | 8.85 | 30.87 | |||
| GNNSF | 3.29 | 0.80 | 0.05 | 1.85 | 4.63 | 13.97 | 48.97 | |||
| ONTTF | 3.73 | (0.09) | 0.00 | (0.13) | 0.00 | 7.60 | 25.80 | |||
| NUVL | 2.06 | (0.08) | 0.00 | (0.16) | 0.00 | 3.54 | 12.24 | |||
| CRNX | 2.52 | (0.56) | 0.00 | (0.71) | 0.00 | 3.33 | 19.41 | |||
| INBX | 2.48 | 0.07 | 0.03 | 0.02 | 3.11 | 5.73 | 16.41 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Innovent Biologics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Innovent Biologics Corporate Management
| Min Liu | Chief Officer | Profile | |
| Blake Salisbury | Sr Devel | Profile | |
| Eduard MD | Pres USA | Profile | |
| Yong MD | President | Profile | |
| Vivian Zhang | Chief Officer | Profile | |
| Dongming Wang | VP Quality | Profile | |
| Changshou Gao | VP CTO | Profile |